Rising investments in the development of advanced microRNA techniques and tools contribute to the global market growth
Market Size – USD 190.6 Million in 2024, Market Growth – CAGR of 11.6%, Market Trends – Introduction of next-generation miRNA sequencing technologies
The global microRNA (miRNA) market size is expected to reach USD 458.0 Million by 2028 at a CAGR of 11.6%, according to a new report by Reports and Data. Significant revenue growth is mainly attributed to increasing research & development programs on genomics and RNA biology, rise in adoption of high-throughput miRNA analysis techniques, and emergence of next-generation miRNA sequencing techniques. Rising prevalence of chronic disorders such as cancer, increasing infectious disease outbreaks such as the ongoing COVID-19 pandemic, and growing applications of miRNA in the pharmaceutical and biotechnology sectors are other key factors responsible for market growth. Furthermore, major advancements in gene sequencing technologies and rise in government investments in life sciences R&D activities bolster the global microRNA (miRNA) market growth.
A microRNA (miRNA) is a small, single-stranded RNA molecule present in animals, plants, and different viruses. Post-transcriptional regulation of gene expression and RNA silencing are two of the key functional areas of miRNAs. miRNAs complement messenger RNA (mRNA) in down-regulating the gene expression and also regulate several vital cellular functions such as cell differentiation, proliferation, and apoptosis. Besides identifying different cell types, they play an indispensable role in cell physiology and development and various pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. miRNAs are present in various mammalian cell types in large numbers. MicroRNA sequencing is a form of RNA sequencing that involves next-generation DNA sequencing technology and is performed by researchers to study miRNA isoforms, tissue-specific expression patterns, and disease associations.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1418
Technological advancements and rapid digitization have streamlined the daily operations of the pharmaceutical industry. Increasing spending on medicine due to growing geriatric populace, rising incidence of chronic diseases, increasing number of product launches, and growing number of R&D activities are some key factors contributing to revenue growth of the market. Increasing focus on patient engagement solutions, rising focus to cater to growing unmet clinical demand, adoption of advanced technologies to streamline workflows in healthcare sector, and availability of skilled healthcare professionals has been positively impacting the pharma & healthcare industry. The emergence of COVID-19 pandemic has further increased focus on healthcare facilities, teleconsultation and telemedicine, and increased burden on the healthcare industry compelling governments and companies to invest heavily to cater to the growing global demand.
Top Companies operating in the Market and Profiled in the Report include:
Agilent Technologies, Exigon, Merck KGA, Illumina, Inc., NanoString Technologies, Inc., and Thermo Fischer Scientific
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1418
MicroRNA (miRNA) Market Segmentation:
Product Type Outlook (Revenue, USD Million; 2024-2028)
- Instruments
- Kits, Reagents, and Consumables
- Isolation & Purification
- Quantification & Detection
- Functional Analysis
- Others
Research Tools and Services Outlook (Revenue, USD Million; 2024-2028)
- Tools
- RT-PCR
- Biomarkers
- Next Gen Sequencing (NGS)
- Microarray Analysis Tools
- Functional Analysis Tools
- Extraction Tools
- Others
- Services
- miRNA cDNA Synthesis
- Quantification Services
- Microarray Services
- Sequencing Services
- Functional Studies Services
- Others
Application Outlook (Revenue, USD Million; 2024-2028)
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
End-use Outlook (Revenue, USD Million; 2024-2028)
- Biopharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Diagnostic Centers
The report discusses in detail the top companies in the market along with their recent initiatives such as mergers and acquisitions, joint venture, partnerships, corporate and government deals, collaborations, and brand promotions and product launches among others. The report further discusses the companies’ initiatives and investments in key regions across the globe such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Region analysis Covers:
- North America (U.S.A., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
To know more about the report @ https://www.reportsanddata.com/report-detail/microrna-mirna-market
In conclusion, the report offers a comprehensive analysis of the factors expected to drive the global MicroRNA (miRNA) market growth over the forecast period of 2024-2028. The report is an all-inclusive document covering the market landscape and a futuristic perspective on its growth and progress. The report also provides an analysis of the entry-level driving and restraining factors for the new entrants contributing to the market. The report also offers strategic recommendations to the established players as well as new entrants to help them gain a strong foothold in the market.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1418
Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.
Read More Reports:-
Rheumatoid Arthritis Drugs Market Key players
Cardiac Surgery Instruments Market
Nuclear Medicine Imaging Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
